**About the Editor**

## **Stanley Stylli**

Stanley Stylli completed his PhD in 2013 at The University of Melbourne. He is a researcher within the Department of Neurosurgery at The Royal Melbourne Hospital and an Honorary Fellow of the Department of Surgery (RMH) at The University of Melbourne. He has a background in glioblastoma research and focuses on invasion, with a particular emphasis on invadopodia and more recently extracellular vesicles. He also has a strong interest in the repurposing of drugs for the treatment of glioblastoma aimed at disrupting invadopodia and exosome-related processes to form the basis of novel anti-invasive therapies that can be utilized in the clinic. He is a member of The Invadosome Consortium, which is an international, open network of laboratories interested in tissue invasion, invadopodia and podosomes.
